Rosetta Genomics Ltd.
Records under this name other than the patents Rosetta Genomics Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,680,067 | Targeting Micrornas for the Treatment of Liver Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 9,150,857 | Targeting Micrornas for the Treatment of Liver Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 9,845,470 | Targeting Micrornas for the Treatment of Liver Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 10,301,627 | Targeting Micrornas for the Treatment of Liver Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 8,211,867 | Targeting Micrornas for the Treatment of Liver Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 8,883,757 | Compositions and Methods for Treatment of Ovarian Cancer Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 8,822,144 | Compositions and Methods for Prognosis and Treatment of Prostate Cancer Lapsed on the fee record Ended Sep 2, 2026 · High confidence | Lapsed on the fee record | Ended Sep 2, 2026 | High confidence |
| US 8,802,599 | Gene Expression Signature for Classification of Tissue of Origin of Tumor Samples Lapsed on the fee record Ended Aug 12, 2026 · Medium confidence | Lapsed on the fee record | Ended Aug 12, 2026 | Medium confidence |
| US 7,888,497 | Bioinformatically Detectable Group of Novel Regulatory Oligonucleotides and Uses Thereof Term ended Term ended Jul 28, 2026 · Medium confidence | Term ended | Term ended Jul 28, 2026 | Medium confidence |
| US 8,765,702 | Composition and Methods for Modulating Cell Proliferation and Cell Death Formerly held Lapsed on the fee record Ended Jul 1, 2026 · High confidence | Lapsed on the fee record | Ended Jul 1, 2026 | High confidence |